Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials

Background Low serum levels of 25-hydroxyvitamin D have been associated with worse outcomes in multiple sclerosis (MS) patients treated with interferon-beta. Association of vitamin D nutrition on the outcomes of other MS therapies has been studied less. Objective Whether patients in the phase 3 fing...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of neurology Ročník 265; číslo 2; s. 348 - 355
Hlavní autori:	Hongell, Kira, Silva, Diego G., Ritter, Shannon, Meier, Daniela Piani, Soilu-Hänninen, Merja
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2018 Springer Nature B.V
Predmet:	25-Hydroxyvitamin D Clinical trials Dietary supplements Gadolinium Lesions Magnetic resonance imaging Medicine & Public Health Multiple sclerosis Neurology Neuroradiology Neurosciences Original Communication Patients Serum levels Vitamin D β-Interferon Vitamin D Fingolimod MRI MS EDSS
ISSN:	0340-5354, 1432-1459, 1432-1459
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!